vs
PUMA BIOTECHNOLOGY, INC.(PBYI)与Stellar Bancorp, Inc.(STEL)财务数据对比。点击上方公司名可切换其他公司
Stellar Bancorp, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍($108.9M vs $75.5M),PUMA BIOTECHNOLOGY, INC.同比增速更快(27.7% vs 0.8%),Stellar Bancorp, Inc.自由现金流更多($92.6M vs $14.4M),过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高(31.3% vs 0.2%)
彪马生物技术是一家公开上市的生物制药企业,总部位于美国加利福尼亚州洛杉矶,专注于创新药物研发相关业务,在生物制药领域开展研发与商业化运营。
Stellar Bancorp, Inc.是总部位于美国的金融控股公司,通过旗下全资银行子公司开展运营,提供全品类零售及商业银行服务,覆盖存款产品、个人及商业贷款、抵押贷款、财富管理解决方案,服务客群包括个人消费者、小微企业及区域企业客户。
PBYI vs STEL — 直观对比
营收规模更大
STEL
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出26.9%
0.8%
自由现金流更多
STEL
多$78.2M
$14.4M
两年增速更快
PBYI
近两年复合增速
0.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $75.5M | $108.9M |
| 净利润 | — | $26.1M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 29.0% |
| 净利率 | — | 24.0% |
| 营收同比 | 27.7% | 0.8% |
| 净利润同比 | — | 3.7% |
| 每股收益(稀释后) | $0.26 | $0.52 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
PBYI
STEL
| Q4 25 | $75.5M | $108.9M | ||
| Q3 25 | $54.5M | $105.6M | ||
| Q2 25 | $52.4M | $104.1M | ||
| Q1 25 | $46.0M | $104.8M | ||
| Q4 24 | $59.1M | $108.0M | ||
| Q3 24 | $80.5M | $107.8M | ||
| Q2 24 | $47.1M | $106.8M | ||
| Q1 24 | $43.8M | $108.4M |
净利润
PBYI
STEL
| Q4 25 | — | $26.1M | ||
| Q3 25 | $8.8M | $25.7M | ||
| Q2 25 | $5.9M | $26.4M | ||
| Q1 25 | $3.0M | $24.7M | ||
| Q4 24 | — | $25.2M | ||
| Q3 24 | $20.3M | $33.9M | ||
| Q2 24 | $-4.5M | $29.8M | ||
| Q1 24 | $-4.8M | $26.1M |
毛利率
PBYI
STEL
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率
PBYI
STEL
| Q4 25 | 22.7% | 29.0% | ||
| Q3 25 | 17.6% | 30.5% | ||
| Q2 25 | 12.7% | 31.7% | ||
| Q1 25 | 8.7% | 29.6% | ||
| Q4 24 | 22.6% | 29.4% | ||
| Q3 24 | 27.4% | 39.6% | ||
| Q2 24 | -4.6% | 35.1% | ||
| Q1 24 | -5.3% | 30.4% |
净利率
PBYI
STEL
| Q4 25 | — | 24.0% | ||
| Q3 25 | 16.2% | 24.3% | ||
| Q2 25 | 11.2% | 25.3% | ||
| Q1 25 | 6.5% | 23.6% | ||
| Q4 24 | — | 23.3% | ||
| Q3 24 | 25.2% | 31.4% | ||
| Q2 24 | -9.6% | 27.9% | ||
| Q1 24 | -11.0% | 24.1% |
每股收益(稀释后)
PBYI
STEL
| Q4 25 | $0.26 | $0.52 | ||
| Q3 25 | $0.17 | $0.50 | ||
| Q2 25 | $0.12 | $0.51 | ||
| Q1 25 | $0.06 | $0.46 | ||
| Q4 24 | $0.40 | $0.47 | ||
| Q3 24 | $0.41 | $0.63 | ||
| Q2 24 | $-0.09 | $0.56 | ||
| Q1 24 | $-0.10 | $0.49 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $419.5M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $1.7B |
| 总资产 | $216.3M | $10.8B |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势,按日历期对齐
现金及短期投资
PBYI
STEL
| Q4 25 | $97.5M | $419.5M | ||
| Q3 25 | $94.4M | $728.4M | ||
| Q2 25 | $96.0M | $578.1M | ||
| Q1 25 | $93.2M | $560.6M | ||
| Q4 24 | $101.0M | $911.2M | ||
| Q3 24 | $96.7M | $516.2M | ||
| Q2 24 | $96.8M | $490.3M | ||
| Q1 24 | $107.2M | $399.7M |
总债务
PBYI
STEL
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益
PBYI
STEL
| Q4 25 | $130.3M | $1.7B | ||
| Q3 25 | $115.3M | $1.7B | ||
| Q2 25 | $104.7M | $1.6B | ||
| Q1 25 | $97.1M | $1.6B | ||
| Q4 24 | $92.1M | $1.6B | ||
| Q3 24 | $71.1M | $1.6B | ||
| Q2 24 | $48.5M | $1.6B | ||
| Q1 24 | $51.0M | $1.5B |
总资产
PBYI
STEL
| Q4 25 | $216.3M | $10.8B | ||
| Q3 25 | $202.9M | $10.6B | ||
| Q2 25 | $194.9M | $10.5B | ||
| Q1 25 | $196.2M | $10.4B | ||
| Q4 24 | $213.3M | $10.9B | ||
| Q3 24 | $220.7M | $10.6B | ||
| Q2 24 | $205.0M | $10.7B | ||
| Q1 24 | $214.1M | $10.7B |
负债/权益比
PBYI
STEL
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $14.4M | $97.0M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $92.6M |
| 自由现金流率自由现金流/营收 | 19.1% | 85.0% |
| 资本支出强度资本支出/营收 | 0.0% | 4.0% |
| 现金转化率经营现金流/净利润 | — | 3.71× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $173.2M |
8季度趋势,按日历期对齐
经营现金流
PBYI
STEL
| Q4 25 | $14.4M | $97.0M | ||
| Q3 25 | $9.7M | $63.6M | ||
| Q2 25 | $14.1M | $25.8M | ||
| Q1 25 | $3.6M | $-5.7M | ||
| Q4 24 | $15.6M | $132.6M | ||
| Q3 24 | $11.0M | $59.5M | ||
| Q2 24 | $1.0M | $38.1M | ||
| Q1 24 | $11.2M | $31.1M |
自由现金流
PBYI
STEL
| Q4 25 | $14.4M | $92.6M | ||
| Q3 25 | $9.7M | $62.5M | ||
| Q2 25 | $14.1M | $24.5M | ||
| Q1 25 | $3.6M | $-6.4M | ||
| Q4 24 | $15.6M | $128.0M | ||
| Q3 24 | $11.0M | $57.7M | ||
| Q2 24 | $1.0M | $37.1M | ||
| Q1 24 | — | $30.5M |
自由现金流率
PBYI
STEL
| Q4 25 | 19.1% | 85.0% | ||
| Q3 25 | 17.7% | 59.2% | ||
| Q2 25 | 26.8% | 23.6% | ||
| Q1 25 | 7.7% | -6.2% | ||
| Q4 24 | 26.4% | 118.5% | ||
| Q3 24 | 13.7% | 53.5% | ||
| Q2 24 | 2.1% | 34.8% | ||
| Q1 24 | — | 28.2% |
资本支出强度
PBYI
STEL
| Q4 25 | 0.0% | 4.0% | ||
| Q3 25 | 0.0% | 1.1% | ||
| Q2 25 | 0.0% | 1.2% | ||
| Q1 25 | 0.1% | 0.7% | ||
| Q4 24 | 0.0% | 4.3% | ||
| Q3 24 | 0.0% | 1.7% | ||
| Q2 24 | 0.0% | 0.9% | ||
| Q1 24 | 0.0% | 0.5% |
现金转化率
PBYI
STEL
| Q4 25 | — | 3.71× | ||
| Q3 25 | 1.10× | 2.48× | ||
| Q2 25 | 2.41× | 0.98× | ||
| Q1 25 | 1.21× | -0.23× | ||
| Q4 24 | — | 5.26× | ||
| Q3 24 | 0.54× | 1.76× | ||
| Q2 24 | — | 1.28× | ||
| Q1 24 | — | 1.19× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图